Pharmahungary Group as a Hungarian SME is ready for Horizon 2020 applications and are offering innovative preclinical and clinical R&D services.
It is with great sadness that we announce the passing of Jacques van Rooyen, PhD
Clinical trials with Medical Devices. Good Clinical Practice lecture by Clinical Director
Realising the therapeutic potential of novel cardioprotective therapies, COST Action
Pharmahungary Group joins COST Action, CardioRNA